Market Overview

Mid-Morning Market Update: Markets Edge Lower; Tyson Profit Misses Estimates


Following the market opening Monday, the Dow traded down 0.12 percent to 20,982.70 while the NASDAQ declined 0.09 percent to 6,095.48. The S&P also fell, dropping 0.07 percent to 2,397.58.

Leading and Lagging Sectors

Energy sector was the top gainer in the US market on Monday. Top gainers in the sector included Kosmos Energy Ltd (NYSE: KOS), Northern Oil & Gas, Inc. (NYSE: NOG), and Approach Resources Inc. (NASDAQ: AREX).

In trading on Monday, basic materials shares were relative laggards, down on the day by about 0.67 percent. Meanwhile, top losers in the sector included Northwest Pipe Company (NASDAQ: NWPX), down 4 percent, and Koppers Holdings Inc. (NYSE: KOP), down 3 percent.

Top Headline

Tyson Foods, Inc. (NYSE: TSN) posted downbeat earnings for its first quarter on Monday.

Tyson said it earned $1.01 per share in the first quarter on revenue of $9.08 billion; Analysts were expecting the company to earn $1.02 per share on revenue of $9.05 billion.

Tyson Foods expects FY 2017 earnings of $4.90 to $5.05 per share, versus analysts’ estimates of $5.02 per share.

Equities Trading UP

Straight Path Communications Inc (NYSE: STRP) shares shot up 30 percent to $210.41. Straight Path Communications disclosed that the $184 per share bid from a multi-national telecom company is superior to AT&T's bid.

Shares of SGOCO Group Ltd (NASDAQ: SGOC) got a boost, shooting up 18 percent to $1.89 after the company reported the purchase of Century Skyway Limited.

Petmed Express Inc (NASDAQ: PETS) shares were also up, gaining 16 percent to $28.00 after the company posted upbeat quarterly results.

Equities Trading DOWN

Horizon Pharma PLC (NASDAQ: HZNP) shares dropped 32 percent to $10.64 as the company posted downbeat Q1 earnings and lowered its FY 2017 guidance. The company also announced plans to acquire River Vision for $145 million in cash.

Shares of TherapeuticsMD Inc (NYSE: TXMD) were down around 22 percent to $3.66 after the company after the company announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration. The letter is in response to the company's New Drug Application (NDA) for its investigational applicator-free estradiol vaginal softgel capsule called TX-004HR. TherapeuticsMD said in its press release that while the letter didn't identify any issues related to the efficacy of the therapy, the FDA couldn't approve TX-004HR at this time. Specifically, the FDA cited a lack of long-term endometrial safety data beyond the 12-week period, which was explored in a Phase 3 clinical study called Rejoice Trial.

Kite Pharma Inc (NASDAQ: KITE) was down, falling around 10 percent to $73.39 as the company posted a wider-than-expected Q1 loss.


In commodity news, oil traded down 0.65 percent to $45.92 while gold traded up 0.42 percent to $1,232.00.

Silver traded up 0.28 percent Monday to $16.32, while copper fell 1.66 percent to $2.4865.


European shares were lower today. The eurozone’s STOXX 600 dropped 0.25 percent, the Spanish Ibex Index fell 0.76 percent, while Italy’s FTSE MIB Index slipped 0.46 percent. Meanwhile the German DAX dropped 0.24 percent, and the French CAC 40 declined 0.97 percent while U.K. shares rose 0.11 percent.


The Consumer Board Employment Trends Index rose to 132.64 for April, versus a prior reading of 131.40.

The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

The TD Ameritrade Investor Movement Index for April will be released at 12:30 p.m. ET.

Posted-In: Earnings M&A News Guidance Eurozone Commodities Global Intraday Update


Related Articles (AREX + HZNP)

View Comments and Join the Discussion!

Micron Catalysts Having Largely Materialized, Goldman Removes From Buy List

Benzinga's Bulls And Bears For The Past Week: Semiconductors And Warren Buffett